Marshall Wace North America’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-3,857
| Closed | -$1.6M | – | 1382 |
|
|
2021
Q2 | $1.6M | Buy |
3,857
+2,335
| +153% | +$968K | 0.01% | 846 |
|
|
2021
Q1 | $595K | Sell |
1,522
-663
| -30% | -$259K | ﹤0.01% | 1130 |
|
|
2020
Q4 | $1.22M | Buy |
+2,185
| New | +$1.22M | 0.01% | 888 |
|
|
2020
Q3 | – | Sell |
-510
| Closed | -$404K | – | 1218 |
|
|
2020
Q2 | $404K | Buy |
+510
| New | +$404K | ﹤0.01% | 960 |
|
|
2020
Q1 | – | Sell |
-3,019
| Closed | -$3.43M | – | 1241 |
|
|
2019
Q4 | $3.43M | Buy |
3,019
+3,004
| +20,027% | +$3.41M | 0.02% | 457 |
|
|
2019
Q3 | $17K | Buy |
+15
| New | +$17K | ﹤0.01% | 1238 |
|
|
2019
Q2 | – | Sell |
-36,744
| Closed | -$74.9M | – | 1181 |
|
|
2019
Q1 | $74.9M | Buy |
+36,744
| New | +$74.9M | 0.53% | 51 |
|
|
2018
Q3 | – | Sell |
-14,264
| Closed | -$29M | – | 944 |
|
|
2018
Q2 | $29M | Buy |
+14,264
| New | +$29M | 0.16% | 148 |
|
|
2018
Q1 | – | Sell |
-20,500
| Closed | -$47.3M | – | 1434 |
|
|
2017
Q4 | $47.3M | Buy |
20,500
+3,885
| +23% | +$8.96M | 0.26% | 85 |
|
|
2017
Q3 | $29.5M | Sell |
16,615
-10,278
| -38% | -$18.2M | 0.19% | 146 |
|
|
2017
Q2 | $36.6M | Buy |
26,893
+11,618
| +76% | +$15.8M | 0.27% | 88 |
|
|
2017
Q1 | $18M | Buy |
+15,275
| New | +$18M | 0.14% | 186 |
|
|
2013
Q4 | $267K | Sell |
984
-174
| -15% | -$47.2K | 0.01% | 616 |
|
|
2013
Q3 | $404K | Buy |
+1,158
| New | +$404K | 0.01% | 480 |
|